Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
ADT Intensification: The Evidence You Can’t Afford to Miss
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Erica L. Mayer, MD, MPH
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Targeting PTEN: Why It Matters
Case: Implementing ADT Intensification in mHSPC
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
Maria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
The Future of Biologic Treatment in IBD: What’s on the Horizon
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
The Evolving Role of Small Molecules in IBD Care
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Putting It All Together: A Practical IBD Treatment Selection Primer
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
Robert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.